ULTRACHO Trademark
Trademark Overview
On Thursday, February 5, 2026, a trademark application was filed for ULTRACHO with the United States Patent and Trademark Office. The USPTO has given the ULTRACHO trademark a serial number of 99637342. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Thursday, June 4, 2026. This trademark is owned by Biointron Biological Inc.. The ULTRACHO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Research in the field of DNA sequencing technology; Research in the field of DNA mutation; Research and development services in the field of antibodies; Research and development of antibody-drug conjugates; Scientific laboratory services; Research and development of conjugated antibodies; Biological research and analysis; Laboratory services for biomanufacturing; Providing laboratory research services in the field of gene expression, namely, cancer biology; Cell culture services for scientific and research purposes, for others; Research and development of new products for others; Research in the field of cell engineering technology; Technical research in the field of pharmaceutical studies; Medical research; Scientific research in the field of genetics and genetic engineering
General Information
| Serial Number | 99637342 |
| Word Mark | ULTRACHO |
| Filing Date | Thursday, February 5, 2026 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Thursday, June 4, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Research in the field of DNA sequencing technology; Research in the field of DNA mutation; Research and development services in the field of antibodies; Research and development of antibody-drug conjugates; Scientific laboratory services; Research and development of conjugated antibodies; Biological research and analysis; Laboratory services for biomanufacturing; Providing laboratory research services in the field of gene expression, namely, cancer biology; Cell culture services for scientific and research purposes, for others; Research and development of new products for others; Research in the field of cell engineering technology; Technical research in the field of pharmaceutical studies; Medical research; Scientific research in the field of genetics and genetic engineering |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 5, 2026 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Biointron Biological Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Shanghai 201318
CN |
Trademark Events
| Event Date | Event Description |
| Thursday, February 5, 2026 | NEW APPLICATION ENTERED |
| Thursday, February 5, 2026 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, June 3, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, June 4, 2026 | ASSIGNED TO EXAMINER |
| Thursday, June 4, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
